Skip to main content
Clinical Trials/NL-OMON42526
NL-OMON42526
Completed
N/A

Platelet reactivity and formation of platelet-monocyte complexes in patients with chronic obstructive pulmonary disease (COPD) - COPD reactivity

ongziekten0 sites50 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
COPD chronic obstructive pulmonary disease
Sponsor
ongziekten
Enrollment
50
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
ongziekten

Eligibility Criteria

Inclusion Criteria

  • In order to be eligible to participate in this study the COPD subjects must meet all of the following criteria:
  • \>40 years
  • Bronchus obstruction detected by spirometry: FEV1/FVC ratio \< 70% and postbronchodilatory FEV1\<80% (COPD Gold II\-IV) and clinical diagnosis confirmed by a pulmonologist.
  • \>\=10 pack years of smoking

Exclusion Criteria

  • Use of aspirin or other platelet function inhibitors
  • Chronic inflammatory diseases, such as rheumatoid arthritis, psoriasis, inflammatory bowel diseases , systemic lupus erythematous (SLE)
  • Malignancies
  • Regarding the control subjects the inclusion criteria described above do not apply, however the exclusion criteria do apply.

Outcomes

Primary Outcomes

Not specified

Similar Trials